Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3583798 | 0.94 | PDE5A (1.00) | PDE5A | |
| SCHEMBL3571129 | 0.94 | PDE5A (1.00) | PDE5A | |
| SCHEMBL3579337 | 0.93 | PDE5A (0.92) | PDE5A | |
| SCHEMBL314744 | 0.91 | PDE5A (0.83) | PDE5A | |
| SCHEMBL3586171 | 0.89 | PDE5A (0.85) | PDE5A | |
| SCHEMBL3579878 | 0.89 | PDE5A (0.80) | PDE5A | |
| SCHEMBL3576801 | 0.88 | PDE5A (0.89) | PDE5A | |
| SCHEMBL3584230 | 0.88 | PDE5A (0.78) | PDE5A | |
| SCHEMBL3585469 | 0.88 | PDE5A (1.00) | PDE5A | |
| SCHEMBL3575752 | 0.88 | PDE5A (0.84) | PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572214-A1 | MORPHOLINE DERIVATIVES FOR USE AS DOPAMINE AGONISTS IN THE TREATMENT OF I.A. SEXUAL DYSFUNCTION | Pfizer Limited (GB) | 2005-09-14 | — | — | EP | disclosed |
| EP-1501800-A1 | BOMBESIN ANTAGONISTS | Warner-Lambert Company LLC (US) | 2005-02-02 | — | — | EP | disclosed |
| WO-2004052372-A1 | MORPHOLINE DERIVATIVES FOR USE AS DOPAMINE AGONISTS IN THE TREATMENT OF I.A. SEXUAL DYSFUNCTION | PFIZER LIMITED (GB) | 2004-06-24 | — | — | WO | disclosed |
| WO-2003092670-A1 | BOMBESIN ANTAGONISTS | WARNER-LAMBERT COMPANY LLC (US) | 2003-11-13 | — | — | WO | disclosed |